Furthermore, its approval can help companies secure additional funding and facilitate pipeline generation. However, pre-clinical toxicology studies can present a bottleneck for companies on the path ...

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which ...

The growth of the global Preclinical CRO market is driven by several key factors. Increasing complexity and costs associated ...

Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical ...

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024Professor Bruce E. Sands, MD to present oral ...

The top development phase for Pulmonary Radiation Toxicity is preclinical with three drugs in that stage. The Pulmonary Radiation Toxicity pipeline has seven drugs in development by companies and 0 by ...

EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...